NasdaqGS - Delayed Quote USD
Gilead Sciences, Inc. (GILD)
109.98
-1.28
(-1.15%)
At close: June 13 at 4:00:01 PM EDT
109.98
0.00
(0.00%)
After hours: June 13 at 7:28:42 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 811,504 | 27 |
| Sales | 356,785 | 11 |
| Net Shares Purchased (Sold) | 454,719 | 38 |
| Total Insider Shares Held | 1.53M | -- |
| % Net Shares Purchased (Sold) | 42.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MERCIER JOHANNA Officer | -- | Direct | -- | Jun 10, 2025 |
| TELMAN DEBORAH H General Counsel | -- | Direct | -- | Jun 10, 2025 |
| O'DAY DANIEL PATRICK Chief Executive Officer | -- | Direct | -- | Jun 10, 2025 |
| WILFONG DIANE E Officer | -- | Direct | -- | Jun 10, 2025 |
| DICKINSON ANDREW D Chief Financial Officer | -- | Direct | -- | Jun 10, 2025 |
| O'DAY DANIEL PATRICK Chief Executive Officer | Sale at price 110.11 - 110.96 per share. | Direct | 1,104,193 | May 30, 2025 |
| MERCIER JOHANNA Officer | Sale at price 107.52 per share. | Direct | 3,010,564 | May 22, 2025 |
| MERCIER JOHANNA Officer | Conversion of Exercise of derivative security at price 66.64 per share. | Direct | 1,666,000 | May 22, 2025 |
| DICKINSON ANDREW D Chief Financial Officer | Sale at price 99.82 per share. | Direct | 249,550 | May 15, 2025 |
| RODRIGUEZ JAVIER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2025 |
| BARTON JACQUELINE K Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2025 |
| WELTERS ANTHONY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2025 |
| MANWANI HARISH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2025 |
| HORNING SANDRA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2025 |
| LOVE TED WENDELL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2025 |
| TELMAN DEBORAH H General Counsel | -- | Direct | -- | Apr 25, 2025 |
| DICKINSON ANDREW D Chief Financial Officer | Sale at price 106.40 per share. | Direct | 266,000 | Apr 15, 2025 |
| DICKINSON ANDREW D Chief Financial Officer | Sale at price 110.53 per share. | Direct | 276,325 | Mar 17, 2025 |
| DICKINSON ANDREW D Chief Financial Officer | Sale at price 117.30 - 118.50 per share. | Direct | 2,118,696 | Mar 10, 2025 |
| TELMAN DEBORAH H General Counsel | -- | Direct | -- | Mar 10, 2025 |
| PATTERSON SANDRA Officer | -- | Direct | -- | Mar 10, 2025 |
| MERCIER JOHANNA Officer | -- | Direct | -- | Mar 10, 2025 |
| O'DAY DANIEL PATRICK Chief Executive Officer | -- | Direct | -- | Mar 10, 2025 |
| DICKINSON ANDREW D Chief Financial Officer | Conversion of Exercise of derivative security at price 63.91 per share. | Direct | 1,145,842 | Mar 10, 2025 |
| DICKINSON ANDREW D Chief Financial Officer | Sale at price 104.09 per share. | Direct | 260,225 | Feb 18, 2025 |
| DICKINSON ANDREW D Chief Financial Officer | Sale at price 102.22 per share. | Direct | 14,073,241 | Feb 12, 2025 |
| DICKINSON ANDREW D Chief Financial Officer | Conversion of Exercise of derivative security at price 57.92 - 83.49 per share. | Direct | 9,260,873 | Feb 12, 2025 |
| TELMAN DEBORAH H General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| PATTERSON SANDRA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| MERCIER JOHANNA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| O'DAY DANIEL PATRICK Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| DICKINSON ANDREW D Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 4, 2025 |
| DICKINSON ANDREW D Chief Financial Officer | Sale at price 97.22 per share. | Direct | 13,822,740 | Jan 31, 2025 |
| DICKINSON ANDREW D Chief Financial Officer | Conversion of Exercise of derivative security at price 57.92 - 72.34 per share. | Direct | 9,600,576 | Jan 31, 2025 |
| TELMAN DEBORAH H General Counsel | -- | Direct | -- | Jan 24, 2025 |
| DICKINSON ANDREW D Chief Financial Officer | Sale at price 91.35 per share. | Direct | 228,375 | Jan 15, 2025 |
| DICKINSON ANDREW D Chief Financial Officer | Sale at price 91.96 per share. | Direct | 781,660 | Dec 16, 2024 |
| PATTERSON SANDRA Officer | -- | Direct | -- | Dec 13, 2024 |
| PATTERSON SANDRA Officer | -- | Direct | -- | Dec 10, 2024 |
| PARSEY MERDAD V Officer | -- | Direct | -- | Dec 10, 2024 |
| TELMAN DEBORAH H General Counsel | -- | Direct | -- | Dec 10, 2024 |
| O'DAY DANIEL PATRICK Chief Executive Officer | -- | Direct | -- | Dec 10, 2024 |
| MERCIER JOHANNA Officer | -- | Direct | -- | Dec 10, 2024 |
| DICKINSON ANDREW D Chief Financial Officer | -- | Direct | -- | Dec 10, 2024 |
| DICKINSON ANDREW D Chief Financial Officer | Sale at price 92.76 - 92.77 per share. | Direct | 23,065,271 | Nov 29, 2024 |
| DICKINSON ANDREW D Chief Financial Officer | Conversion of Exercise of derivative security at price 57.92 - 73.77 per share. | Direct | 17,528,577 | Nov 29, 2024 |
| PARSEY MERDAD V Officer | Sale at price 91.79 - 92.00 per share. | Direct | 15,094,013 | Nov 27, 2024 |
| PARSEY MERDAD V Officer | Conversion of Exercise of derivative security at price 57.92 - 65.38 per share. | Direct | 9,079,689 | Nov 27, 2024 |
| BLUESTONE JEFFREY Director | Sale at price 91.39 per share. | Direct | 620,356 | Nov 26, 2024 |
| BLUESTONE JEFFREY Director | Conversion of Exercise of derivative security at price 61.17 - 61.35 per share. | Direct | 612,442 | Nov 26, 2024 |
Related Tickers
BMY Bristol-Myers Squibb Company
49.75
-1.85%
AMGN Amgen Inc.
295.22
-0.70%
ABBV AbbVie Inc.
191.08
-0.70%
MRK Merck & Co., Inc.
81.71
-0.13%
BIIB Biogen Inc.
130.65
-1.25%
GSK GSK plc
40.86
-3.84%
JNJ Johnson & Johnson
157.10
+0.28%
AZN AstraZeneca PLC
74.42
-0.77%
PFE Pfizer Inc.
24.54
-1.21%
NVS Novartis AG
119.45
-1.09%